Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Loreen Walker"'
Autor:
Jeannie Marie S. Leoutsakos, Christine Franey, Paul B. Rosenberg, Gail Beth Rattinger, Pankdeep Chhabra, Ilene H. Zuckerman, Linda Simoni-Wastila, Loreen Walker, Patricia Langenberg, Sarah K. Dutcher, Xinggang Liu
Publikováno v:
Journal of the American Geriatrics Society. 62:1046-1055
Objectives: To assess the effectiveness of medications used in the management of Alzheimer's disease and related dementias (ADRD) on cognition and activity of daily living (ADL) trajectories and to determine whether sex modifies these effects. Design
Autor:
Loreen Walker, Clarissa J. Diamantidis, Min Zhan, Stephen L. Seliger, Gail Beth Rattinger, Van Doren Hsu, Jeffrey C. Fink
Publikováno v:
American Journal of Kidney Diseases. 60:47-53
Chronic kidney disease is a high-risk condition for a variety of adverse safety events, yet little is known about differential rates of safety events across racial groups with decreased kidney function. We sought to examine the incidence of an array
Autor:
Stephen L. Seliger, Jeffrey C. Fink, Kathleen M. Fox, Brian D. Bradbury, Chiun-Fang Chiou, Loreen Walker, Shravanthi R. Gandra, Van Doren Hsu
Publikováno v:
Clinical Journal of the American Society of Nephrology. 5:882-888
The severity of anemia at which to initiate erythropoiesis-stimulating agent (ESA) treatment in nondialysis chronic kidney disease (CKD) patients is unclear. Risk of mortality, hospitalizations, and blood transfusion were compared among nondialysis C
Publikováno v:
Clinical Journal of the American Society of Nephrology. 5:95-101
Background and objectives: Chronic kidney disease (CKD) lacks standardized patient safety indicators (PSIs); however, undetected safety events are likely to contribute to adverse outcomes in this disease. This study sought to determine the proportion
Autor:
Sarah K. Dutcher, Loreen Walker, Ilene H. Zuckerman, Linda Simoni-Wastila, Yujin Park, Gail Beth Rattinger, Jacqueline B. Palmer, Jennifer S. Albrecht
Older adults with dementia are vulnerable to the central deteriorating effects of drugs with anticholinergic properties (DAPs). These effects include falls and confusion and may exacerbate dementia-related symptoms. Many individuals with dementia als
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee53d6eb533859502a5ecdaa32c9aaf
https://europepmc.org/articles/PMC4527604/
https://europepmc.org/articles/PMC4527604/
Autor:
Loreen Walker, Jennifer S. Ginsberg, Clarissa J. Diamantidis, Gail Beth Rattinger, Min Zhan, Jeffrey C. Fink, Iris R. Hartley
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 8(12)
Summary Background and objectives The Agency for Healthcare and Research Quality patient safety indicators track adverse safety events in hospitalized patients but overlook safety incidents specific to CKD. This study considers candidate CKD-pertinen
Autor:
Ilene H. Zuckerman, Paul B. Rosenberg, Sarah K. Dutcher, Loreen Walker, Christine Franey, Linda Simoni-Wastila, Mehmet Burcu, Pankdeep Chhabra, Gail Beth Rattinger
Publikováno v:
Journal of the American Geriatrics Society. 61(5)
Objectives: To describe population-based use of cognitive-enhancing and psychopharmacological medications across care settings in Medicare beneficiaries with dementia. Design: One-year (2008) cross-sectional study. Setting: Medicare administrative cl
Autor:
Loreen Walker, Mehmet Burcu, Gail Beth Rattinger, Ilene H. Zuckerman, Linda Simoni-Wastila, Christine Franey, Pankdeep Chhabra, Sarah K. Dutcher
Publikováno v:
Alzheimer's & Dementia. 8
Autor:
Christine Franey, Linda Simoni-Wastila, Patricia Langenberg, Sarah K. Dutcher, Loreen Walker, Ilene H. Zuckerman, Pankdeep Chhabra, Gail Beth Rattinger
Publikováno v:
Alzheimer's & Dementia. 8
Autor:
Matthew R. Weir, Krupa Patel, James F. Gardner, Van Doren Hsu, Jeffrey C. Fink, Loreen Walker, Clarissa J. Diamantidis, Min Zhan
Publikováno v:
American journal of nephrology. 36(1)
Background: Non-steroidal anti-inflammatory drugs (NSAIDs), including cyclooxygenase-2 (COX-2) inhibitors, are generally contraindicated in chronic kidney disease (CKD). This investigation sought to identify the frequency of NSAID/COX-2 prescription